- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 6 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 7 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
More Regulatory News
Stem Cell Therapy Indications for Neurological Disorders in Phase II Clinical Trials
Stem cell therapies are being developed for several different indications. In April we reviewed...
- Posted July 10, 2014
Stem Cell Therapy Indications for Cardiovascular Disease in Phase II/III Clinical Trials
While there are stem cell therapies in development for several different indications, the number...
- Posted April 10, 2014
Interesting Late Stage Viral Vaccine Candidates
In March, the Pharmaceutical Research and Manufacturers of America released a new report “Medicines...
- Posted May 9, 2013
Fifteen Cell and Stem Cell Therapies in Phase III Clinical Trials – Part I
Last week, The Dish posted a blog titled “Biologics Have a Robust Pipeline According...
- Posted March 28, 2013
Biologics Have a Robust Pipeline According to Latest PhRMA Report
Earlier this month, the Pharmaceutical Research and Manufacturers of America released a new report...
- Posted March 21, 2013